{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:29:44Z","timestamp":1791322184238,"version":"4.3.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/dad.0b013e3182604d96","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T03:04:01Z","timestamp":1344567841000},"page":"827-832","source":"Crossref","is-referenced-by-count":11,"title":["Mitotic Rate in Cutaneous Melanomas \u22641 mm in Thickness"],"prefix":"10.1097","volume":"34","author":[{"given":"Brandon R.","family":"Litzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka N.","family":"Etufugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Stepenaskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay J.","family":"Cockerell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":". Increasing burden of melanoma in the United States.","volume":"129","author":"Linos","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/cncr.11624","article-title":". Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.","volume":"98","author":"McKinnon","year":"2003","journal-title":"Cancer"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":". Sentinel-node biopsy or nodal observation in melanoma.","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archsurg.143.9.892","article-title":". Importance of sentinel lymph node biopsy in patients with thin melanoma.","volume":"143","author":"Wright","year":"2008","journal-title":"Arch Surg"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cncr.24044","article-title":". Meta-analysis of sentinel lymph node positivity in thin melanoma (1 mm).","volume":"115","author":"Warycha","year":"2009","journal-title":"Cancer"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/path.1710970305","article-title":"Histology and prognosis in malignant melanoma.","volume":"97","author":"Cochran","year":"1969","journal-title":"J Pathol"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bjc.1968.52","article-title":". Malignant melanoma of the skin: prognostic value of histology in 89 cases.","volume":"22","author":"Williams","year":"1968","journal-title":"Br J Cancer"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1245\/ASO.2006.02.021","article-title":". Results of sentinel lymph node biopsy in patients with thin melanoma.","volume":"13","author":"Wong","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1245\/ASO.2004.10.002","article-title":". Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness 1 mm).","volume":"11","author":"Stitzenberg","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/ASO.2004.07.014","article-title":". The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.","volume":"11","author":"Francken","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2391::AID-CNCR14>3.0.CO;2-I","article-title":". Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma.","volume":"85","author":"Ostmeier","year":"1999","journal-title":"Cancer"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":". Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma.","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","article-title":". Predictors of regional nodal disease in patients with thin melanomas.","volume":"13","author":"Karakousis","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","article-title":". The prognostic importance of sentinel lymph node biopsy in thin melanoma.","volume":"13","author":"Ranieri","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1245\/ASO.2005.04.027","article-title":". Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.","volume":"12","author":"Kesmodel","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1245\/s10434-010-0986-3","article-title":"2010 TNM staging system for cutaneous melanoma and beyond.","volume":"17","author":"Gershenwald","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0560.2011.01699.x","article-title":"AJCC melanoma staging update: impact on dermatopathology practice and patient management.","volume":"38","author":"Piris","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/DAD.0b013e3181faab45","article-title":"The magic of numbers: malignant melanoma between science and pseudoscience.","volume":"33","author":"Weyers","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0b013e3181cf7cc1","article-title":". Use of anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.","volume":"32","author":"Casper","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/DAD.0b013e3181624054","article-title":"Comparison of pHH3, Ki-67, and surviving immunoreactivity in benign and malignant melanocytic lesions.","volume":"30","author":"Nasr","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00000478-200312000-00011","article-title":". Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas.","volume":"27","author":"Scolyer","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/DAD.0b013e3181d7ce6f","article-title":". Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis.","volume":"32","author":"Glatz","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archsurg.2009.271","article-title":". Predictors of occult nodal metastasis in patients with thin melanoma.","volume":"145","author":"Faries","year":"2010","journal-title":"Arch Surg"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.amjsurg.2003.08.010","article-title":". Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.","volume":"186","author":"Fincher","year":"2003","journal-title":"Am J Surg"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10434-000-0469-z","article-title":". Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience.","volume":"7","author":"Cascinelli","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","article-title":". Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.","volume":"16","author":"Gershenwald","year":"1998","journal-title":"J Clin Oncol"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10434-000-0461-7","article-title":". Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up.","volume":"7","author":"Statius Muller","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","article-title":". Guidelines of care for the management of primary cutaneous melanoma.","volume":"65","author":"Bichakjian","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0039-6060(03)00275-7","article-title":". Cost-effectiveness of sentinel lymph node biopsy in thin melanomas.","volume":"134","author":"Agnese","year":"2003","journal-title":"Surgery"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1245\/s10434-009-0780-2","article-title":". Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.","volume":"17","author":"Leiter","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2133.2005.06941.x","article-title":". Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.","volume":"153","author":"Gutzmer","year":"2005","journal-title":"Br J Dermatol"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000078580","article-title":". Is sentinel lymph node biopsy of therapeutic relevance for melanoma.","volume":"209","author":"Mohrle","year":"2004","journal-title":"Dermatology"},{"key":"R34-7-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejso.2004.06.021","article-title":". Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.","volume":"30","author":"Wasserberg","year":"2004","journal-title":"Eur J Surg Oncol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-201212000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:18:59Z","timestamp":1643973539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201212000-00007"}},"subtitle":["A Prospective Study"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3182604d96","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717973638.793470238","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}